Bacil Pharma Ltd — Board Meeting, 13-11-2025: Board Meeting
13-11-2025 | 07:36 pm
13-11-2025 | 07:36 pm
Bacil Pharma's board approved Q2/H1 FY26 results. Q2 Profit for Period: ₹0.01 Cr; H1 Profit: ₹0.74 Cr. Auditors flagged concerns on preferential allotment, related parties, advances, and tax compliance due to documentation issues.
No comments yet. Be the first to comment!
